cytarabine has been researched along with Cardiomyopathies in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Liu, L; Qu, Q; Wu, D; Zhang, Y | 1 |
| Bourquin, JP; Creutzig, U; Dworzak, M; Henze, G; Kremens, B; Lakomek, M; Reinhardt, D; Stary, J; Urban, C; Zimmermann, M | 1 |
| Beyer, U; Gnad-Vogt, SU; Hochhaus, A; Hofheinz, RD | 1 |
| Lamm, RD; McCarthy, PM; Sade, RM | 1 |
| Gould, PA; Hengel, CL; Kaye, DM; Russell, PA | 1 |
| Mizuta, K; Okuma, M; Sawada, H; Sawai, H; Takeda, Y; Tashima, M; Toi, T | 1 |
| Balduzzi, A; Galli, MA; Longoni, D; Nicolini, B; Tagliabue, A; Uderzo, C | 1 |
| Appelt, M; Büchner, T; Eichelbaum, M; Grille, W; Hiddemann, W; Hossfeld, DK; Koslowski, B; Kraft, J; Kuse, R; Quabeck, K | 1 |
1 review(s) available for cytarabine and Cardiomyopathies
| Article | Year |
|---|---|
Liposomal encapsulated anti-cancer drugs.
Topics: Animals; Anthracyclines; Antineoplastic Agents; Camptothecin; Cardiomyopathies; Clinical Trials as Topic; Cytarabine; Humans; Liposomes; Neoplasms; Platinum Compounds; Vincristine | 2005 |
2 trial(s) available for cytarabine and Cardiomyopathies
| Article | Year |
|---|---|
Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses.
Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Recurrence; Survival Analysis; Treatment Outcome; Tretinoin | 2010 |
Effects of verapamil on anthracycline-induced cardiomyopathy: preliminary results of a prospective multicenter trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cytarabine; Daunorubicin; Hemodynamics; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Thioguanine; Verapamil | 1990 |
5 other study(ies) available for cytarabine and Cardiomyopathies
| Article | Year |
|---|---|
Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia.
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Cytarabine; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Kidney Diseases; Leukemia, Myeloid, Acute; Male; Middle Aged; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2015 |
Medical ethics collides with public policy: LVAD for a patient with leukemia.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cost-Benefit Analysis; Cytarabine; Health Care Rationing; Heart-Assist Devices; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Public Policy; United States | 2005 |
Subacute anthracycline cardiotoxicity.
Topics: Adult; Antibiotics, Antineoplastic; Cardiomyopathies; Cytarabine; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Male; Ultrasonography | 2006 |
[Ischemic hepatitis due to anthracycline-induced cardiac insufficiency in a patient with acute myelocytic leukemia (M0)].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cytarabine; Doxorubicin; Etoposide; Female; Hepatitis; Humans; Ischemia; Leukemia, Myeloid, Acute; Liver; Remission Induction | 1995 |
Mild pre-transplant cardiomyopathy may not impair long-term quality of life after bone marrow transplantation.
Topics: Acute Disease; Anthracyclines; Bone Marrow Transplantation; Cardiomyopathies; Child; Cytarabine; Daunorubicin; Electroencephalography; Graft vs Host Disease; Humans; Immunosuppressive Agents; Karnofsky Performance Status; Leukemia, Myeloid; Male; Quality of Life; Transplantation, Homologous | 2000 |